Abstract

BackgroundOvarian squamous cell carcinoma (SCC) is a rare cancer with possible poor survival, however no direct evidence supports this viewpoint and the independent prognostic factors are controversial. Patients with ovarian SCC and serous carcinoma (SC) who were diagnosed between 2004 and 2016 were selected using the recent released SEER database. Propensity score matching was used to balance the characteristics of the two groups. The difference of survival between patients with ovarian SCC and SC was explored using Kaplan-Meier method. Cox regression analyses were performed to further identify the independent prognostic factors among patients with ovarian SCC.ResultsOf 15,286 patients (15,106 SC cases and 180 SCC cases), 304 were identified in the matched cohort (200 SC cases and 104 SCC cases). The overall survival and cause-specific survival for patients with SCC were significantly poorer (Plog-rank < 0.001). The median survival time was 21 months for SCC and 95 months for SC. Patients who underwent bilateral salpingo-oophorectomy with hysterectomy and omentectomy seemed to have a better outcome. In multivariate analysis, older age at diagnosis, larger tumor size, bilateral and FIGO stage IV malignancy were the independent risk factors for poor disease outcome.ConclusionsThe prognosis of ovarian SCC is worse than ovarian SC. Older age at diagnosis, advanced disease stage, larger tumor size and bilateral malignancy are the independent risk factors for poor survival.

Highlights

  • Ovarian squamous cell carcinoma (SCC) is a rare cancer with possible poor survival, no direct evidence supports this viewpoint and the independent prognostic factors are controversial

  • Ovarian cancer encompasses a heterogeneous group of malignancies and epithelial cancers account for 90%

  • Squamous cell carcinoma (SCC) of ovary is a rare entity that constitutes less than 1% of the total ovarian carcinoma cases [3]

Read more

Summary

Introduction

Ovarian squamous cell carcinoma (SCC) is a rare cancer with possible poor survival, no direct evidence supports this viewpoint and the independent prognostic factors are controversial. Squamous cell carcinoma (SCC) of ovary is a rare entity that constitutes less than 1% of the total ovarian carcinoma cases [3]. This disease predominantly arises from malignant transformation of mature cystic teratoma. Patients with ovarian SCC have been reported to have a worse disease outcome [6]. Systematic reviews have combined previously reported cases and discussed the features and prognostic factors for patients with MCT-SCC [7,8,9]. The previous findings need to be investigated by a new study based on the latest population data

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call